Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2024ANZ Journal of SurgeryOpen Access

Complexity of surgery and treatment burden in patients with peritoneal malignancy is not determined by addition of hyperthermic intraperitoneal chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDaniel SteffensNANabila AnsariCKCherry Koh

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Steffens et al. (2024) studied this question.

synapsesocial.com/papers/68e75573b6db6435876cd8a8https://doi.org/10.1111/ans.18933
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Morbidity and mortality of patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy2024 · 3 citations
  2. 2Impact of surgical volume and learning curve on postoperative complications and surgical infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)2025
  3. 3Long-Term Outcomes following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin2024 · 7 citations
  4. 4Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Sarcomatosis2024 · 1 citations
  5. 5Evaluation of the Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Long-Term Survival and Morbidity Profile: A Systematic Review of the Peritoneal Carcinomatosis Management2026 · 1 citations